anacardic acid has been researched along with rivastigmine in 1 studies
| Studies (anacardic acid) | Trials (anacardic acid) | Recent Studies (post-2010) (anacardic acid) | Studies (rivastigmine) | Trials (rivastigmine) | Recent Studies (post-2010) (rivastigmine) |
|---|---|---|---|---|---|
| 177 | 1 | 120 | 1,397 | 266 | 633 |
| Protein | Taxonomy | anacardic acid (IC50) | rivastigmine (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Electrophorus electricus (electric eel) | 6.2943 | |
| Cholinesterase | Homo sapiens (human) | 1.1886 | |
| Acyl-CoA desaturase 1 | Rattus norvegicus (Norway rat) | 1.71 | |
| Acetylcholine receptor subunit epsilon | Rattus norvegicus (Norway rat) | 9 | |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.875 | |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.875 | |
| Acetylcholinesterase | Mus musculus (house mouse) | 3.9833 | |
| Acetylcholinesterase | Homo sapiens (human) | 2.8567 | |
| Acetylcholinesterase | Bos taurus (cattle) | 0.62 | |
| Cholinesterase | Canis lupus familiaris (dog) | 6.27 | |
| Acetylcholinesterase | Rattus norvegicus (Norway rat) | 3.5012 | |
| Tyrosine-protein kinase SYK | Homo sapiens (human) | 0.16 | |
| Beta-secretase 1 | Homo sapiens (human) | 7.72 | |
| Cholinesterase | Equus caballus (horse) | 2.1636 | |
| Cholinesterase | Mus musculus (house mouse) | 0.829 | |
| Carboxylic ester hydrolase | Rattus norvegicus (Norway rat) | 5.2767 | |
| Carboxylic ester hydrolase | Equus caballus (horse) | 0.495 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolognesi, ML; da Costa Nunes, JL; de Oliveira Miranda, C; de Oliveira, AS; Gandini, A; Gervasoni, S; Jung, M; Kobrlova, T; Massenzio, F; Monti, B; Petralla, S; Rossi, M; Senger, J; Simões Heyn Roth Cardoso, G; Soares Romeiro, LA; Soukup, O; Vistoli, G | 1 |
1 other study(ies) available for anacardic acid and rivastigmine
| Article | Year |
|---|---|
Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer's Disease.
Topics: | 2019 |